Aaron Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Buy
2,655
+264
+11% +$54.7K 0.03% 410
2026
Q1
$537K Buy
2,391
+453
+23% +$113K 0.03% 375
2025
Q4
$467K Sell
1,938
-2,210
-53% -$565K 0.03% 454
2025
Q3
$1.14M Buy
4,148
+2,448
+144% +$669K 0.07% 202
2025
Q2
$439K Buy
1,700
+201
+13% +$47.9K 0.04% 271
2025
Q1
$336K Sell
1,499
-108
-7% -$25.2K 0.04% 302
2024
Q4
$368K Buy
1,607
+323
+25% +$77.8K 0.04% 271
2024
Q3
$313K Buy
+1,284
New +$287K 0.04% 287
2022
Q2
Sell
-73,965
Closed -$305K 701
2022
Q1
$305K Buy
+73,965
New +$17.9M ﹤0.01% 662

Other funds holding RMD

Aaron Wealth Advisors's RMD Position: Q2 2026 in Review

Aaron Wealth Advisors increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $54.7K and bringing the position to 2,655 shares worth $517K. The position accounts for 0.03% of the portfolio, ranked #410.

Aaron Wealth Advisors first reported a position in RMD in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.14M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Aaron Wealth Advisors held 2,655 shares of ResMed worth $517K as of Q2 2026.
  • Aaron Wealth Advisors bought 264 ResMed shares in Q2 2026, an estimated $54.7K.
  • ResMed made up 0.03% of Aaron Wealth Advisors's portfolio in Q2 2026, its #410 holding.
  • Aaron Wealth Advisors first reported a position in ResMed in Q1 2022 and has held it in 9 quarters since.
  • Aaron Wealth Advisors's ResMed position peaked at $1.14M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.